ZA99733B - Ophthalmic composition. - Google Patents

Ophthalmic composition.

Info

Publication number
ZA99733B
ZA99733B ZA9900733A ZA99733A ZA99733B ZA 99733 B ZA99733 B ZA 99733B ZA 9900733 A ZA9900733 A ZA 9900733A ZA 99733 A ZA99733 A ZA 99733A ZA 99733 B ZA99733 B ZA 99733B
Authority
ZA
South Africa
Prior art keywords
ophthalmic composition
ophthalmic
composition
Prior art date
Application number
ZA9900733A
Other languages
English (en)
Inventor
Ryuji Ueno
Ichie Kato
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Publication of ZA99733B publication Critical patent/ZA99733B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9900733A 1998-01-30 1999-01-29 Ophthalmic composition. ZA99733B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1983698 1998-01-30

Publications (1)

Publication Number Publication Date
ZA99733B true ZA99733B (en) 1999-08-02

Family

ID=12010371

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9900733A ZA99733B (en) 1998-01-30 1999-01-29 Ophthalmic composition.

Country Status (16)

Country Link
US (2) US6403598B1 (xx)
EP (2) EP1004307B1 (xx)
KR (1) KR20010040457A (xx)
CN (1) CN1295476A (xx)
AR (1) AR018272A1 (xx)
AT (1) ATE223219T1 (xx)
AU (1) AU2184499A (xx)
BR (1) BR9907715A (xx)
CA (1) CA2318516A1 (xx)
DE (1) DE69902738T2 (xx)
HU (1) HUP0100214A3 (xx)
IL (1) IL137128A0 (xx)
NO (1) NO20003786L (xx)
TR (1) TR200002209T2 (xx)
WO (1) WO1999038497A2 (xx)
ZA (1) ZA99733B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000043015A1 (fr) * 1999-01-25 2000-07-27 Fujisawa Pharmaceutical Co., Ltd. Gouttes ophtalmologiques
AU2001256855A1 (en) * 2000-05-08 2001-11-20 N.V. Nutricia Preparation for the prevention and treatment of ocular disorders
DE10045343B4 (de) * 2000-09-14 2005-05-12 Neuhann, Tobias, Dr.med. Verwendung einer wässrigen Lösung oder Suspension zum Heilen des Hornhautepithels
EP1539193A4 (en) * 2002-07-03 2010-05-05 Pericor Science Inc HYALURONIC ACID COMPOSITIONS AND METHODS OF USE
CA2566098A1 (en) * 2004-05-11 2005-11-17 Santen Pharmaceutical Co., Ltd. Therapeutic agent for keratoconjunctival disorder
US20060275278A1 (en) * 2005-06-02 2006-12-07 Choy Camus K M Method and ophthalmic formulation for eye protection or treatment
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
TW200738243A (en) * 2005-11-15 2007-10-16 Glaxo Group Ltd Novel process and formulations
US8158667B2 (en) 2006-08-21 2012-04-17 Kador Peter F Topical treatment of cataracts in dogs
US20090093446A1 (en) * 2007-10-05 2009-04-09 Winston Laboratories, Inc. Method for alleviating keratoconjunctivitis sicca
WO2015095515A1 (en) * 2013-12-20 2015-06-25 Novartis Ag Sgc activators for the treatment of glaucoma
AR108280A1 (es) * 2016-05-05 2018-08-08 Acraf Composición oftálmica que comprende una combinación sinérgica de glucógeno y ácido hialurónico o sal del mismo
EP3672598A4 (en) 2017-08-24 2021-04-28 The Regents of The University of California OCULAR PHARMACEUTICAL COMPOSITIONS
US11166925B2 (en) 2018-08-23 2021-11-09 Elorac, Inc. Method for alleviating keratoconjunctivitis sicca

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474967A (en) * 1983-04-27 1984-10-02 Pfizer Inc. 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione
JPS6143114A (ja) * 1984-08-03 1986-03-01 Takeda Chem Ind Ltd 虹彩・毛様体疾患治療用眼局所投与剤
GB8524663D0 (en) * 1985-10-07 1985-11-13 Fujisawa Pharmaceutical Co Quinazoline derivatives
US5360611A (en) * 1988-10-03 1994-11-01 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation
JPH0782259A (ja) * 1993-09-14 1995-03-28 Senju Pharmaceut Co Ltd スクシンアミド酸誘導体及びそれを含有する糖尿病合併症治療剤

Also Published As

Publication number Publication date
CN1295476A (zh) 2001-05-16
NO20003786D0 (no) 2000-07-24
US20020161015A1 (en) 2002-10-31
TR200002209T2 (tr) 2000-11-21
AR018272A1 (es) 2001-11-14
WO1999038497A3 (en) 2000-03-09
EP1004307A2 (en) 2000-05-31
US6476039B1 (en) 2002-11-05
HUP0100214A2 (hu) 2002-02-28
DE69902738D1 (de) 2002-10-10
EP1161942A2 (en) 2001-12-12
IL137128A0 (en) 2001-07-24
BR9907715A (pt) 2000-10-17
ATE223219T1 (de) 2002-09-15
WO1999038497A2 (en) 1999-08-05
KR20010040457A (ko) 2001-05-15
EP1161942A3 (en) 2003-12-10
NO20003786L (no) 2000-07-24
HUP0100214A3 (en) 2002-10-28
EP1004307B1 (en) 2002-09-04
AU2184499A (en) 1999-08-16
CA2318516A1 (en) 1999-08-05
DE69902738T2 (de) 2003-02-06
US6403598B1 (en) 2002-06-11

Similar Documents

Publication Publication Date Title
ZA996185B (en) Sulfanylsilanes.
ZA200005136B (en) Dihydropyrimides.
DE69941083D1 (en) 12,13-cyclopropan-epothilonderivate
EG24814A (en) Novel compounds.
ZA984849B (en) Compositions.
ZA200004956B (en) Vaccine composition.
ZA978178B (en) Composition.
ZA99254B (en) Benzosulfone derivatives.
ZA975261B (en) Composition.
AU138171S (en) Goggles
HK1036412A1 (en) Anit-inflammatory eye drops.
ZA991272B (en) Novel thiobenzamides.
MXPA01002531A (es) Composicion cosmetica.
ZA200005510B (en) Pharmaceutical composition.
ZA99733B (en) Ophthalmic composition.
ZA992443B (en) Hydroxy-methyl-hexanones.
ZA991550B (en) Cyclohexanediole derivatives.
ZA9811502B (en) Novel composition.
ZA995325B (en) Methylcyclotetradec-5-en-1-ones.
ZA993123B (en) Trisresorcinyltriazines.
MXPA01004833A (es) Temporizador de pre-paginacion.
ZA993197B (en) Pesticidal composition.
HK1044117A1 (en) Pharmaceutical composition.
ZA200006118B (en) Novel composition.
GB0029720D0 (en) I.S machine7544232001